EPA:ALDMS - FR0012202497 - Common Stock
The current stock price of ALDMS.PA is 1.34 EUR. In the past month the price decreased by -2.19%. In the past year, price increased by 38.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 27.17 | 198.13B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 58.13 | 143.59B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 57.44 | 141.67B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.77 | 135.43B | ||
2M6.DE | MEDTRONIC PLC | 16.79 | 101.90B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 19.85 | 53.29B | ||
BOX.DE | BECTON DICKINSON AND CO | 13.35 | 46.68B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 31.72 | 40.97B | ||
1DXCM.MI | DEXCOM INC | 44.81 | 25.13B | ||
DC4.DE | DEXCOM INC | 44.03 | 25.04B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.53 | 22.93B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.53 | 22.92B |
Diagnostic Medical Systems engages in the development, design, and production of medical imaging systems. The company is headquartered in Gallargues-Le-Montueux, Occitanie and currently employs 152 full-time employees. The firm manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The firm operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
DIAGNOSTIC MEDICAL SYSTEMS
9 Avenue du Canal Philippe
Gallargues-le-Montueux OCCITANIE FR
Employees: 129
Phone: 33467504900
The current stock price of ALDMS.PA is 1.34 EUR.
The exchange symbol of DIAGNOSTIC MEDICAL SYSTEMS is ALDMS and it is listed on the Euronext Paris - Matif exchange.
ALDMS.PA stock is listed on the Euronext Paris - Matif exchange.
10 analysts have analysed ALDMS.PA and the average price target is 2.09 EUR. This implies a price increase of 56.04% is expected in the next year compared to the current price of 1.34. Check the DIAGNOSTIC MEDICAL SYSTEMS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) has a market capitalization of 35.71M EUR. This makes ALDMS.PA a Nano Cap stock.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) currently has 129 employees.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) has a support level at 1.33 and a resistance level at 1.35. Check the full technical report for a detailed analysis of ALDMS.PA support and resistance levels.
The Revenue of DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) is expected to grow by 15.57% in the next year. Check the estimates tab for more information on the ALDMS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALDMS.PA does not pay a dividend.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
ChartMill assigns a technical rating of 6 / 10 to ALDMS.PA. When comparing the yearly performance of all stocks, ALDMS.PA is one of the better performing stocks in the market, outperforming 89.21% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to ALDMS.PA. Both the profitability and financial health of ALDMS.PA have multiple concerns.
Over the last trailing twelve months ALDMS.PA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 40% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -5.34% | ||
ROE | -22.44% | ||
Debt/Equity | 0.9 |
10 analysts have analysed ALDMS.PA and the average price target is 2.09 EUR. This implies a price increase of 56.04% is expected in the next year compared to the current price of 1.34.